PHILADELPHIA--(BUSINESS WIRE)--Scientists and researchers from 17 universities and research institutions in Pennsylvania, New Jersey and Delaware have been invited to submit proposals for the third round of the University City Science Center’s QED Proof-of-Concept Funding Program.
The RFP was released on June 24 to: Children’s Hospital of Philadelphia, Delaware State University, Drexel University, Fox Chase Cancer Center, Harrisburg University of Science and Technology, Lankenau Institute for Medical Research, Lehigh University, Monell Chemical Senses Center, Philadelphia College of Osteopathic Medicine, Rutgers, The State University of New Jersey, Temple University, Thomas Jefferson University, University of Delaware, University of Pennsylvania, University of the Sciences in Philadelphia, Widener University, The Wistar Institute.
The QED Program (from the Latin “Quod Erat Demonstrandum” – “that which is demonstrated”) integrates four elements that are critical to successfully and efficiently performing early-stage proof-of-concept technology assessments: grant funding, business advice, market drivers and guidance to exit. The program was launched in April 2009.
To read the full, original article click on this link: Science Center’s QED Program Issues RFP For Third Round of Proof-of-Concept Program | Business Wire
Author: Press Release
